The combination of lenalidomide and dexamethasone reduced bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation
The combination of lenalidomide and dexamethasone reduced bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation